Targeting Proteomics to Decipher Biology for the Drug Development Pipeline

In this webinar, Jeffrey Silva, PhD, Principal Scientist in the Proteomics Group at Cell Signaling Technology, will provide an overview of how mass spectrometry-based proteomics can be used for drug discovery and development. Dr. Silva will also present several case studies highlighting how these techniques can be used to gain a deeper understanding of disease mechanisms and as a powerful tool for drug discovery.

Visit the Proteomics Analytics Services resource center for more information.